...
首页> 外文期刊>Leukemia Research: A Forum for Studies on Leukemia and Normal Hemopoiesis >Intracellular P-gp contributes to functional drug efflux and resistance in acute myeloid leukaemia.
【24h】

Intracellular P-gp contributes to functional drug efflux and resistance in acute myeloid leukaemia.

机译:细胞内P-gp有助于急性骨髓性白血病的功能性药物外流和耐药性。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Drug compartmentalization as well as drug efflux can contribute to drug resistance. We demonstrate the presence of P-gp in intracellular vesicles in certain AML cell lines and show localization of DNR to a similar subcellular compartment(s) that can be altered in the presence of P-gp inhibitors. Analysis of leukaemic cell lines and 50 AML patient samples showed that the level of P-gp mRNA or total P-gp protein correlated better with drug efflux than surface P-gp protein, suggesting that intracellular P-gp may contribute to MDR in AML. Therefore, the level of total P-gp protein or mRNA may be a better indicator of MDR than surface P-gp protein. In addition, we provide evidence for a novel mechanism of drug sequestration in K562 myeloid leukaemic cells.
机译:药物分隔以及药物外排可导致耐药性。我们证明了某些AML细胞系中细胞内囊泡中P-gp的存在,并显示了DNR在类似的亚细胞区室中的定位,在存在P-gp抑制剂的情况下它可以改变。对白血病细胞系和50例AML患者样本的分析表明,P-gp mRNA或总P-gp蛋白水平与药物外排比表面P-gp蛋白更好,这表明细胞内P-gp可能有助于AML中的MDR。因此,总P-gp蛋白或mRNA的水平可能比表面P-gp蛋白更好地指示了MDR。此外,我们为K562髓样白血病细胞中的隔离药物的新机制提供了证据。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号